Global  

WHO set to resume hydroxychloroquine trial to battle covid-19

Video Credit: HT Digital Content - Duration: 02:33s - Published
WHO set to resume hydroxychloroquine trial to battle covid-19

WHO set to resume hydroxychloroquine trial to battle covid-19

World Health Orgnanisation (WHO) said hydroxychloroquine (HCQ) will return to solidarity trial for potential treatment covid-19.

The UN body had paused trials of the anti-malarial drug citing a Lancet study.

The study had suggested the drug could cause more fatalities among Covid-19 patients.

At a press conference in the WHO headquarters in Geneva, Director General Tedros Adhanom Ghebreyesus said, “The Executive Group received this recommendation and endorsed continuation of all arms of the solidarity trial, including hydroxychloroquine.” Watch the video for more.

0
shares
ShareTweetSavePostSend
 

You Might Like


Tweets about this


Related videos from verified sources

'WHO should've researched independently’: CSIR welcomes HCQ trial resumption [Video]

'WHO should've researched independently’: CSIR welcomes HCQ trial resumption

Council of Scientific and Industrial Research (CSIR) welcomed WHO’s move to resume hydroxychloroquine trials. WHO on Thursday said HCQ will return to solidarity trial for potential treatment for..

Credit: HT Digital Content     Duration: 01:41Published
Hydroxychloroquine no better than placebo, study finds [Video]

Hydroxychloroquine no better than placebo, study finds

The malaria drug promoted by U.S. President Donald Trump as a treatment for COVID-19 was ineffective in preventing infection in people exposed to the coronavirus, according to a widely anticipated..

Credit: Reuters - Politics     Duration: 01:56Published